MedTrace Logo

Interventions for Postoperative Delirium: Biomarker-2 (IPOD-B2)

NCT02926417 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2021-11-01

No results posted yet for this study

Summary

The IPOD-B2 Study aims to understand the pathogenesis of postoperative delirium in patients undergoing major surgery. The investigators will identify then correlate soluble biomarkers in blood and cerebral spinal fluid with changes in High Density-Electroencephalogram.

Conditions

  • Delirium

Interventions

PROCEDURE

High Density-Electroencephalogram

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Richard Lennertz, MD PhD · University of Wisconsin-Madison, School of Medicine and Public Health

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2019-11-26
Completion
2019-11-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02926417 on ClinicalTrials.gov